Health Sciences › Medicine › Oncologie › Immunothérapie du cancer et biomarqueurs

Immunothérapie du cancer et biomarqueurs

This cluster of papers focuses on the advances in cancer immunotherapy research, particularly in the context of immune checkpoint blockade targeting PD-1 and PD-L1, the impact of tumor microenvironment, biomarkers for immunotherapy response, T-cell exhaustion, neoantigens, tumor mutational burden, immune-related adverse events, and the exploration of combination therapies. The research also delves into the intricate mechanisms of cancer immunoediting.

Questions & réponses

Aucune question publiée pour cette rubrique. Posez la première ci-dessous.